ESR1 and breast cancer: Another study found that Matrigel plugs mixed with ER+ breast cancer cells from estrogen-treated, ovariectomized mice had lower expression levels of soluble VEGFR-1, increased bioavailability of VEGF protein, and increased angiogenesis, compared to untreated controls (117).